I hope so too groins. I can't imagine that cost was the issue here though, if AD was the primary target of PBT2 and cost was the prohibiting factor then why run a trial of 109 participants for HD?
There's just something I'm missing here and it is making me nervous.
Hoping someone out there knows the answer!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $91.27M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.419K | 1.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 63876237 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 4097409 | 8 |
View Market Depth
| Last trade - 16.15pm 04/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |